Barclays Capital today reaffirms its equal weight investment rating on Spirax-Sarco Engineering PLC (LON:SPX) and raised its price target to 9380p (from 8300p).
Barclays Capital today reaffirms its equal weight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 2350p (from 2200p).
Pharmaceutical company Hemogenyx Pharmaceutical said it would be participating at this year's Cancer Immunotherapy Symposia set to take place on August 17-19.
Barclays Capital today reaffirms its underweight investment rating on Capital & Counties Properties PLC (LON:CAPC) and cut its price target to 130p (from 160p).
Respiratory diseases focused Verona Pharma posted a second-quarter loss on the back of R&D spending and said it planned to start a clinical trial of...